Holder Michael 4

What Happened

• Michael, a director of MDxHealth SA (MDXH), received a grant of 10,000 stock options on June 1, 2026. The filing reports this as an award/derivative transaction (code A); the grant is reported at $0.00 because it is an option award rather than an immediate cash purchase.
• The options have an exercise (strike) price of $0.76 per ordinary share (total exercise cost to purchase all shares would be $7,600 if exercised). The options vest in full on the date of the annual general shareholders' meeting in the calendar year following the grant year (i.e., at MDxHealth’s 2027 AGM).

Key Details

• Transaction date: 2026-06-01; Form 4 filed: 2026-06-03 (appears timely).
• Instrument: Options to purchase 10,000 ordinary shares (derivative), exercise price $0.76.
• Reported acquisition value: $0.00 (award/grant); exercise cost if/when exercised: $7,600 total.
• Vesting: Vest in full at the company’s AGM in the calendar year after grant (per footnote).
• Shares owned after transaction: not disclosed in the filing.

Context

• This was an option grant (not an immediate share purchase or sale). Grants are common compensation for executives/directors and do not necessarily indicate a near-term purchase or sale of stock.
• If Michael later exercises these options, that would be a separate transaction and would be reported on a subsequent Form 4.